UDCA supplementation group (UDCA + phototherapy) | Control group (phototherapy only) | ||||||
---|---|---|---|---|---|---|---|
No | Author | Phototherapy duration (hours) | Last mean bilirubin reported (mg/dL) | Phototherapy duration (hours) | Last mean bilirubin reported (mg/dL) | Type of phototherapy lamp | Thresholds for phototherapy |
1 | Akefi [25] | 34.6 (16.3) | – | 35.7 (18.2) | – | Simple phototherapy | Standard curve |
2 | El-Gendy [26] | 65.2 (12.8) | 9.42 (0.82) (96 h) | 82.5 (19.4) | 10.5 (1.35) (96 h) | Single PT | – |
3 | Gharehbaghi [27] | 29.47 (16.8) | 4.75 (1.07) (discharge)* | 45.97 (18.01) | 7.88 (2.11) (discharge)* | LED | AAP guidelines, termination: decrease in TSB < 50% exchange threshold or TSB < 10 mg/dl |
4 | Hassan [28] | 23.2 (5.6) | 7.6 (0.9) (36 h) | 41.1 (7.2) | 9.1 (0.8) (48 h) | LED | – |
5 | Honar [21] | 15.5 (6) | 9.8 (0.2) (48 h) | 44.6 (13.3) | 10.1 (1.1) (48 h) | Daylight fluorescent | Until TSB < 10 mg/dL |
6 | Jafari [29] | – | 14.61 (2.29) (16 h) | – | 12.58 (2.25) (36 h) | – | Until TSB normalised |
7 | Meena [30] | – | 9.48 (0.68) (48 h) | – | 9.99 (0.66) (48 h) | LED | Until TSB < 10 mg/dL |
8 | Shahramian [31] | – | – | – | – | Daylight fluorescent | Until TSB < 10 mg/dL |